A Study of BL-M11D1 in Patients With Relapsed/Refractory Myelodysplastic Syndromes
Clinical trial NCT07591168 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07591168
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-12-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.